Literature DB >> 2118477

Arachidonic acid metabolism in heat-shock treated human leucocytes.

M Köller1, W König.   

Abstract

Human neutrophil granulocyte fractions (PMN) and lymphocytes/monocytes/basophils (LMB) were stimulated with A23187 (7.3 microM), opsonized zymosan (1 mg) or FMLP (10(-5) M) after heat-shock treatment. We observed a temperature- (pretreatment over 40 degrees) and time-dependent (incubation periods longer than 20 min) suppression in the generation of LTB4, LTB4 metabolites and isomers, as well as LTC4 and 5-HETE. These effects were not reversed after the addition of exogenous arachidonic acid (AA;50 microM). In contrast, heat-shock treatment alone triggered platelets to generate 12-HETE. After 1 hr at 42 degrees, 135 +/- 24 ng of 12-HETE were generated from 1 x 10(8) cells. The 12-HETE generation was not dependent on extracellular Ca2+. Conversion of 14C-AA (2 nmol) revealed an enhanced metabolism of AA to 12-HETE by platelets after heat-shock treatment without exogenous Ca2+. PMN and LMB labelled with 35S-methionine led to heat-shock protein (HSP; 65,000, 83,000 MW) expression after heat-shock treatment at 42 degrees or in the presence of NDGA (1 x 10(-5) M) at 37 degrees. These results suggest a regulatory interaction between the generation of lipo-oxygenase products, cellular stress responses and the expression of HSP.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118477      PMCID: PMC1384249     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

Review 1.  The heat shock response.

Authors:  E A Craig
Journal:  CRC Crit Rev Biochem       Date:  1985

Review 2.  The heat-shock response.

Authors:  S Lindquist
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

Review 3.  Lipid mediators produced through the lipoxygenase pathway.

Authors:  C W Parker
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

Review 4.  Burns.

Authors:  R H Demling
Journal:  N Engl J Med       Date:  1985-11-28       Impact factor: 91.245

5.  Studies on the mechanism of omega-hydroxylation of platelet 12-hydroxyeicosatetraenoic acid (12-HETE) by unstimulated neutrophils.

Authors:  A J Marcus; L B Safier; H L Ullman; N Islam; M J Broekman; C von Schacky
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

6.  Mechanism of action of glucocorticosteroids. Inhibition of T cell proliferation and interleukin 2 production by hydrocortisone is reversed by leukotriene B4.

Authors:  J S Goodwin; D Atluru; S Sierakowski; E A Lianos
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

7.  Leukotrienes as mediators of ischemia and shock.

Authors:  A M Lefer
Journal:  Biochem Pharmacol       Date:  1986-01-15       Impact factor: 5.858

8.  Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids.

Authors:  M Croset; M Lagarde
Journal:  Biochem Biophys Res Commun       Date:  1983-05-16       Impact factor: 3.575

9.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

Authors:  B Samuelsson
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

10.  Heat-shock protein synthesis by human polymorphonuclear cells.

Authors:  N S Eid; R E Kravath; K W Lanks
Journal:  J Exp Med       Date:  1987-05-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Microbial pathogenicity and host defense in burned patients--the role of inflammatory mediators.

Authors:  W König; B Schlüter; J Scheffer; M Köller
Journal:  Infection       Date:  1992       Impact factor: 3.553

2.  Arachidonic acid induces DNA-fragmentation in human polymorphonuclear neutrophil granulocytes.

Authors:  M Köller; P Wachtler; A Dávid; G Muhr; W König
Journal:  Inflammation       Date:  1997-10       Impact factor: 4.092

3.  Leukotriene A4 modulates generation of leukotriene B4 and sulphidopeptide leukotrienes by human neutrophils.

Authors:  R A Hilger; W König
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.